申请人:Bhatti Balwinder Singh
公开号:US20120053168A1
公开(公告)日:2012-03-01
The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).
本发明涉及与神经尼古丁乙酰胆碱受体结合并调节其活性的化合物,制备这些化合物的方法,包含这些化合物的药物组合物,以及使用这些化合物治疗各种疾病和疾病的方法,包括与中枢神经系统(CNS)功能障碍有关的疾病和疾病。